Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2016 Mar 25;54(4):1176. doi: 10.1128/JCM.02648-15

Closing the Brief Case: A Reactive HIV Rapid Antibody Test in a Pregnant Woman

Melanie L Yarbrough 1, Neil W Anderson 1,
Editor: A J McAdam
PMCID: PMC4809947

ANSWERS TO SELF-ASSESSMENT QUESTIONS

  1. After a positive HIV rapid antibody test, which of the following tests should be ordered next?
    • (a) HIV-1 Western blot assay.
    • (b) HIV-1 nucleic acid amplification test.
    • (c) HIV antigen/antibody immunoassay.
    • (d) HIV-1/2 differentiation assay.

Answer: c. According to the 2014 CDC recommendations for the diagnostic testing of HIV, patients with positive rapid antibody assay results should be tested by the fourth-generation algorithm in its entirety. Therefore, the most appropriate next test is the HIV antigen/antibody immunoassay.

  1. In a low-risk patient, which of the following results require confirmatory testing with a qualitative molecular assay for HIV-1 as the next step?
    • (a) HIV antigen/antibody immunoassay positive and HIV-1/2 differentiation assay negative.
    • (b) HIV antigen/antibody immunoassay positive and HIV-1/2 differentiation assay positive.
    • (c) HIV rapid antibody test positive and HIV antigen/antibody immunoassay negative.
    • (d) HIV rapid antibody test positive and HIV antigen/antibody immunoassay positive.

Answer: a. The fourth-generation testing algorithm recommends confirmatory testing using a qualitative molecular technique for all patients with positive antigen/antibody immunoassay positive and negative HIV-1/2 differentiation assays. This is to detect possible cases of acute HIV-1.

  1. Which of the following is not an advantage of using the HIV-1/2 differentiation assay for serologic confirmation as opposed to Western blot assay?
    • (a) An earlier time to positivity following infection.
    • (b) The ability to distinguish HIV-1 antibodies from HIV-2 antibodies.
    • (c) The ability to rule out HIV infection based on a negative result.
    • (d) A faster turnaround time.

Answer: c. HIV-1/2 differentiation has an earlier time to positivity, faster turnaround time, and lower cost than HIV-1 Western blotting. Negative results still require confirmation with a molecular test to rule out acute HIV.

TAKE-HOME POINTS.

  • Compared to third-generation antibody assays, fourth-generation antigen/antibody assays are more sensitive, more specific, and capable of earlier detection of HIV infection.

  • Testing for HIV by the fourth-generation algorithm entails screening with an antigen/antibody assay and confirmatory testing with an HIV-1/2 differentiation assay.

  • Patients with a reactive antigen/antibody assay but nonreactive HIV-1/2 differentiation assay should have molecular testing performed to distinguish acute HIV infection from a false-positive screen result.

  • Rapid HIV antibody tests offer a quick turnaround time, but reactive results should be confirmed using the fourth-generation algorithm.

(See page 826 in this issue [doi:10.1128/JCM.02647-15] for case presentation and discussion.)


Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES